Liraglutide treatment induced a slight reduction of body weight during the first week of administration in WT and Wfs1 KO animals (Figure 1a), in agreement with our previous work using GLP1 receptor agonists in this rat model of WS [19,20,21]. The gene discussed is GLP1R; the disease is Werner syndrome.